US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sanofi SA

54.95

+1.232.29%

Post-market: 49.47-5.4850-9.98%16:54 EDT

Volume:1.69M

Turnover:92.35M

Market Cap:134.52B

PE:20.16

High:55.10

Open:55.02

Low:54.30

Close:53.72

Loading ...

Overview Company News Filings

Biotech Stock Roundup: BMY Down on Study Data, Updates From REGN & More

European Equities Surge Higher in Wednesday Trading; EC Fines Meta, Apple for DMA Violations

Novartis, Sanofi CEOs Say EU Should Hike Drug Prices to Boost Innovation

MT Newswires Live

The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi

AstraZeneca CEO Urges Europe to Spend More on Health or Risk Falling Behind -- Market Talk

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday as Trump Softens Stance on Powell, Tariffs

MT Newswires Live

Sanofi to Invest $17.2 Million in Innate Pharma as Part of Review of 2016 License Agreement

MT Newswires Live

Market Chatter: Trump Administration Mulls Cutting US Drug Prices to International Levels

MT Newswires Live

Trump Mulls Cutting US Drug Prices to International Levels, Reuters Reports

MT Newswires Live

Sanofi Should Report Lower Profit, Sales Amid U.S. Policy Uncertainty -- Earnings Preview

Sanofi SA expected to post earnings of 95 cents a share - Earnings Preview

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria

FDA Approves Dupixent for Chronic Hives in Patients Unresponsive to Antihistamines

MT Newswires Live

Regeneron, Sanofi Get FDA Approval For Dupixent in Skin Disease CSU

Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)

Sanofi, Earendil Labs Sign Licensing Deal for Autoimmune, Inflammatory Bowel Disease Treatments

MT Newswires Live

Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback

Chrissy Teigen - author, entrepreneur, mom to young son with type 1 diabetes - joins Sanofi's Screen For Type 1 movement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SNY/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SNY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNY\",,,,,undefined,":{"symbol":"SNY","market":"US","secType":"STK","nameCN":"Sanofi SA","latestPrice":54.95,"timestamp":1746043200000,"preClose":53.72,"halted":0,"volume":1687093,"hourTrading":{"tag":"盘后","latestPrice":49.465,"preClose":54.95,"latestTime":"16:54 EDT","volume":3121,"amount":171361.82262300001,"timestamp":1746046487679},"delay":0,"floatShares":2205948514,"shares":2448069980,"eps":2.726027,"marketStatus":"Post-Mkt","change":1.23,"latestTime":"04-30 18:08:58 EDT","open":55.02,"high":55.1,"low":54.3,"amount":92345520.44298899,"amplitude":0.014892,"askPrice":54.98,"askSize":75,"bidPrice":52.32,"bidSize":20,"shortable":3,"etf":0,"ttmEps":2.726027,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746057600000},"marketStatusCode":4,"adr":1,"adrRate":0.5,"listingDate":1025496000000,"exchange":"NASDAQ","adjPreClose":53.72,"dividendRate":0.03707,"preHourTrading":{"tag":"盘前","latestPrice":55.06,"preClose":53.72,"latestTime":"09:28 EDT","volume":1805,"amount":99262.88123,"timestamp":1746019680041},"postHourTrading":{"tag":"盘后","latestPrice":49.465,"preClose":54.95,"latestTime":"16:54 EDT","volume":3121,"amount":171361.82262300001,"timestamp":1746046487679},"volumeRatio":0.501825,"impliedVol":0.311,"impliedVolPercentile":0.76},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNY\",,,,,undefined,":{"symbol":"SNY","floatShares":2205948514,"roa":"4.28%","roe":"7.30%","lyrEps":2.29994,"volumeRatio":0.501825,"shares":2448069980,"dividePrice":2.037,"high":55.1,"amplitude":0.014892,"preClose":53.72,"low":54.3,"week52Low":45.8,"pbRate":"1.53","psRate":"2.63","week52High":60.115,"institutionHeld":0.0837,"latestPrice":54.95,"committee":-0.578947,"eps":2.726027,"divideRate":0.03707,"volume":1687093,"delay":0,"ttmEps":2.726027,"open":55.02,"prevYearClose":48.23,"prevWeekClose":52.32,"prevMonthClose":55.46,"prevQuarterClose":55.46,"fiveDayClose":53.02,"twentyDayClose":54.34,"sixtyDayClose":53.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNY\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529617659","title":"Biotech Stock Roundup: BMY Down on Study Data, Updates From REGN & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2529617659","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529617659?lang=en_us&edition=fundamental","pubTime":"2025-04-24 00:37","pubTimestamp":1745426220,"startTime":"0","endTime":"0","summary":"This was a low-key week for the biotech sector before the onset of the first-quarter earnings season. Biotech giant Bristol Myers Squibb BMY was down on data from the schizophrenia study while Regeneron REGN was in the spotlight on updates on key drugs.Bristol Myers announced disappointing top-line results from the phase III ARISE study on schizophrenia drug Cobenfy . The study is evaluating the efficacy and safety of Cobenfy as an adjunctive treatment to atypical antipsychotics in adults with inadequately controlled symptoms of schizophrenia.Treatment with Cobenfy as an adjunctive demonstrated a 2.0-point reduction in the Positive and Negative Syndrome Scale total score compared to placebo with an atypical antipsychotic at week six. However, this data did not reach the threshold for statistical significance for the primary endpoint. Shares of BMY were down following the data announcement.Preliminary analyses suggest that Cobenfy as an adjunctive treatment to an atypical antipsychotic ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stock-roundup-bmy-down-163700964.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4583","LU0320765992.SGD","LU2362541513.USD","BK4559","LU1989771016.USD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","LU0306806265.USD","LU1670710588.SGD","BMY","BK4097","BK4578","PFS","IE0002270589.USD","LU0225284248.USD","IE00B19Z3B42.SGD","LU1868836914.USD","REGN","LU0234570918.USD","LU0225771236.USD","LU1670710661.SGD","LU0053666078.USD","LU2362541273.HKD","IE0002141913.USD","LU0058720904.USD","LU1291159041.SGD","LU2237438978.USD","OS","LU1670711040.USD","LU1839511570.USD","BK4585","BK4532","LU0289739699.SGD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU1670711123.USD","GILD","LU2023250504.SGD","LU2133065610.SGD","IE00B3T34201.USD","LU2089984988.USD","LU0306807586.USD","LU0868494617.USD","LU1093756325.SGD","LU1868837300.USD","LU1430594728.SGD","SNY","CRL","BK4007"],"gpt_icon":0},{"id":"2529465387","title":"European Equities Surge Higher in Wednesday Trading; EC Fines Meta, Apple for DMA Violations","url":"https://stock-news.laohu8.com/highlight/detail?id=2529465387","media":"MT Newswires","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529465387?lang=en_us&edition=fundamental","pubTime":"2025-04-24 00:21","pubTimestamp":1745425314,"startTime":"0","endTime":"0","summary":"The European stock markets closed sharply higher in Wednesday trading as the Stoxx Europe 600 climbed 1.67%, Germany's DAX surged 3.00%, the FTSE 100 rose 0.90% , France's CAC 40 advanced 2.13%, and the Swiss Market Index gained 1.39%.The seasonally adjusted HCOB Flash Eurozone Composite PMI Output Index, based on about 85% of usual survey responses and compiled by S&P Global, declined to 50.1 in April from 50.9 in March, just hovering about the 50-point threshold separating expansion from contraction. The reading was the lowest in four months.And in corporate news, the European Commission said it fined tech giants Apple and Meta Platforms 500 million euros  and 200 million euros, respectively, for violating the Digital Markets Act, which aims to protect consumers from large tech companies. The Commission is trying to \"handicap successful\" American businesses and letting Chinese and European companies adopt different standards, a Meta spokesperson told MT Newswires. \"This isn't just ab","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/european-equities-surge-higher-wednesday-162154541.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1803068979.SGD","IE00BFXG1179.USD","LU0170899867.USD","IE00BJLML261.HKD","LU0949170426.SGD","LU0097036916.USD","BK4559","LU2286300806.USD","META","IE00BJTD4V19.USD","LU1823568750.SGD","LU2543165471.USD","BK4598","LU1815333072.USD","LU2023250843.SGD","LU1582987597.SGD","LU1267930730.SGD","SG9999018865.SGD","MACW.SI","LU2403377893.USD","AAPL","LU1778281490.HKD","LU0077335932.USD","LU2191332357.HKD","LU1914381329.SGD","LU0109391861.USD","LU2108987350.USD","LU0256863902.USD","LU1989772840.SGD","LU0672654240.SGD","LU2430703095.HKD","BK4201","LU2756315318.SGD","SG9999015986.USD","BCS","LU0820562030.AUD","SNY","IE00B5949003.HKD","SG9999002224.SGD","DMA","IE0034235303.USD","LU1989772923.USD","IE00B775H168.HKD","LU0784385170.HKD","LU0082616367.USD","LU1046421795.USD","LU1839511570.USD","SG9999014906.USD","LU2097344431.USD","LU0345769128.USD","LU0965509283.SGD","EC"],"gpt_icon":1},{"id":"2529682519","title":"Novartis, Sanofi CEOs Say EU Should Hike Drug Prices to Boost Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2529682519","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529682519?lang=en_us&edition=fundamental","pubTime":"2025-04-23 21:56","pubTimestamp":1745416573,"startTime":"0","endTime":"0","summary":"Novartis  Chief Executive Vas Narasimhan and Paul Hudson, his counterpart at Sanofi  said Wednesday that EU \"price controls and austerity measures\" are decreasing the bloc's attractiveness for pharmaceutical companies.In a letter to the Financial Times, Narasimhan and Hudson said that the US and China are trying to boost innovation, while in Europe \"launch prices are suppressed, patented medicines' growth capped, and prices reduced when new applications are found.\"\"We see a strong outlook for the US -- thanks to policies and regulations conducive to fast and broad patient access to innovative medicines. Unfortunately, this cannot be said for Europe,\" the CEOs said.\"Against a backdrop of waning European biopharma competitiveness, the uncertainty of tariffs is further reducing incentives to invest in the EU,\" the letter said.\"Europe has leading universities, talent and hospitals. With deregulation and an attractive market for innovation, it can succeed. However, it must act decisively an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0211331839.USD","SNY","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","HUDAU","LU0070302665.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE00BFXG1179.USD","BK4156","IE0009355771.USD","IE00B4R5TH58.HKD","BK4585","IE0002141913.USD","BK4532","LU0320765489.SGD","BK4588","BK4007","NVS","BK4578","LU0208291251.USD","SNYNF"],"gpt_icon":0},{"id":"2529365786","title":"The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi","url":"https://stock-news.laohu8.com/highlight/detail?id=2529365786","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529365786?lang=en_us&edition=fundamental","pubTime":"2025-04-23 21:25","pubTimestamp":1745414700,"startTime":"0","endTime":"0","summary":"Chicago, IL – April 23, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Gilead Sciences GILD, Bristol Myers BMY, Merck MRK, AbbVie ABBV and Sanofi SNY.Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi are all slated to release their quarterly results later this week.Gilead has an impeccable earnings track record so far. It beat earnings estimates in each of the last four quarters, delivering an average surprise of 19.47%. In the last reported quarter, GILD beat earnings estimates by 13.77%.Gilead's flagship HIV therapies — Biktarvy and Descovy — are likely to have boosted the company's top line. However, the company's revenues are likely to have been impacted by the new Medicare Part D model, which increases manufacturer discount obligations during the initial coverage and catastrophi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-gilead-132500143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2237443549.SGD","IE00BVYPNW00.USD","LU2089283258.USD","LU1162221912.USD","LU0265550946.USD","LU0306807586.USD","LU2361044949.HKD","LU2237443465.HKD","LU1116320901.HKD","LU0820561909.HKD","IE00B2B36J28.USD","MYE","LU1670711040.USD","IE00BN8TJ469.HKD","LU2125154778.USD","LU2023250504.SGD","ABBV","LU1023059063.AUD","IE00B7SZLL34.SGD","BMY","BK4532","LU0545039389.USD","LU1074936037.SGD","LU1989772840.SGD","LU1917777945.USD","LU0985320562.USD","BK4126","LU0109394709.USD","LU1244550494.USD","BK4581","LU0238689110.USD","IE0002141913.USD","LU0225771236.USD","LU1670711123.USD","SG9999014542.SGD","LU0256863902.USD","LU2023251221.USD","MRK","LU0738911758.USD","SNY","BK4534","SG9999002224.SGD","SNYNF","BK4583","IE0009355771.USD","IE00B1BXHZ80.USD","LU0211331839.USD","GILD","LU1670710661.SGD","LU0234570918.USD"],"gpt_icon":0},{"id":"2529268811","title":"AstraZeneca CEO Urges Europe to Spend More on Health or Risk Falling Behind -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2529268811","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529268811?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:57","pubTimestamp":1745413020,"startTime":"0","endTime":"0","summary":"1256 GMT - AstraZeneca's Chief Executive officer Pascal Soriot says Europe must boost investment into healthcare, as it has done with defense spending, amid what he calls a shifting world order. \"Europe spends a substantially lower share of GDP on innovative medicines than the U.S. and, as a result, is falling behind in attracting R&D and manufacturing investments, putting its ability to protect the health of its own people at risk,\" Soriot says. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4532","LU2456880835.USD","LU0109394709.USD","NVS","IE0002141913.USD","IE00B4R5TH58.HKD","LU0070302665.USD","BK4588","AZN","LU0320765992.SGD","LU2462157665.USD","BK4578","LU0211331839.USD","LU0320765489.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","LU0208291251.USD","IE00BFTCPJ56.SGD","BK4585","LU2236285917.USD","BK4007","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE00BFXG1179.USD","LU2417539215.USD","SNY","LU1829250122.USD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2529500200","title":"Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday as Trump Softens Stance on Powell, Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2529500200","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529500200?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:43","pubTimestamp":1745412235,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 2.2% and the actively traded Invesco QQQ Trust (QQQ) advanced 2.7% in Wednesday's premarket activity as US President Donald Tr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FAZ","IYH","IPK","US12M.BOND","USO","VHT.AU","RTH","WDS.AU","US2Y.BOND","US3Y.BOND","XLV","PMR","UNG","EEM","WDS","VHT","XLE","IVV","IPHA",".SPX",".DJI",".IXIC","EQR","IYW","RTH.AU","US5Y.BOND","IYE","XLI","US30Y.BOND","IYK","QQQ","US10Y.BOND","US6M.BOND","US7Y.BOND","SLV","SPY.AU","IGV","VDC","SNY","XRT","VIS","EXI","FDN","XLK","ERJ","XLF"],"gpt_icon":1},{"id":"2529524424","title":"Sanofi to Invest $17.2 Million in Innate Pharma as Part of Review of 2016 License Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2529524424","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529524424?lang=en_us&edition=fundamental","pubTime":"2025-04-23 16:48","pubTimestamp":1745398121,"startTime":"0","endTime":"0","summary":"Innate Pharma SA (IPHA) and Sanofi (SNY) have agreed that the latter will invest up to 15 million euros ($17.2 million) in new Innate shares as part of a review of a January 2016 research collaboratio","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IPHYF","IPHA","BK4139","SNY","BK4585","IE00BFXG1179.USD","BK4007","SNYNF","BK4588"],"gpt_icon":0},{"id":"2529587164","title":"Market Chatter: Trump Administration Mulls Cutting US Drug Prices to International Levels","url":"https://stock-news.laohu8.com/highlight/detail?id=2529587164","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529587164?lang=en_us&edition=fundamental","pubTime":"2025-04-22 22:26","pubTimestamp":1745332000,"startTime":"0","endTime":"0","summary":"Drug companies were warned that the Trump administration is weighing linking US medicine prices to the lower amounts paid by other developed nations, Reuters reported Tuesday, citing two pharmaceutical company sources.The policy is expected to come from the agency that oversees Medicare and Medicaid, the report said.Price: 22.41, Change: +0.37, Percent Change: +1.67","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0965508806.USD","LU1699723380.USD","LU0965509283.SGD","LU1059921491.USD","LU2129689431.USD","BK4592","LU0320765489.SGD","BMY","MRK","LU0170899867.USD","IE00B19Z3581.USD","LU2361044949.HKD","LU0203345920.USD","BK4566","AZN","LU0795875086.SGD","LU1989771016.USD","LU1829250122.USD","ABBV","SNY","LU1032466523.USD","LU2089284900.SGD","IE0004445239.USD","IE00BGHQF631.EUR","LU1221951129.SGD","PFE","LU0058720904.USD","IE0002270589.USD","LU1732799900.SGD","NVO","LU0792757196.USD","IE00B42XCP33.USD","JNJ","LU1267930490.SGD","LU2023251221.USD","LU2089283258.USD","LU2360032135.SGD","LU0943347566.SGD","IE0034235303.USD","LU1066053197.SGD","LU2237443895.HKD","NVS","LU1430594728.SGD","LU1883839398.USD","LU1323610961.USD","GSK","LU1571399168.USD","GSK.UK","LU0965509010.AUD","LU0265550946.USD"],"gpt_icon":1},{"id":"2529163587","title":"Trump Mulls Cutting US Drug Prices to International Levels, Reuters Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2529163587","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529163587?lang=en_us&edition=fundamental","pubTime":"2025-04-22 22:21","pubTimestamp":1745331708,"startTime":"0","endTime":"0","summary":"Price: 22.38, Change: +0.34, Percent Change: +1.54","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0965509283.SGD","GSK.UK","LU1699723380.USD","SNY","ABBV","IE0034235303.USD","LU2089284900.SGD","BK4566","LU1066053197.SGD","LU2129689431.USD","LU1221951129.SGD","PFE","IE0004445239.USD","LU0170899867.USD","LU0965508806.USD","LU0943347566.SGD","JNJ","NVS","BK4592","LU1883839398.USD","LU1267930490.SGD","LU1571399168.USD","LU1989771016.USD","LU0965509010.AUD","IE0002270589.USD","LU1032466523.USD","LU2023251221.USD","LU0058720904.USD","LU1430594728.SGD","LU0792757196.USD","IE00BGHQF631.EUR","MRK","LU2360032135.SGD","IE00B42XCP33.USD","LU2237443895.HKD","LU1829250122.USD","IE00B19Z3581.USD","LU1732799900.SGD","LU0265550946.USD","LU0795875086.SGD","LU2089283258.USD","LU1323610961.USD","LU0320765489.SGD","LU0203345920.USD","LU1059921491.USD","GSK","LU2361044949.HKD","AZN","BMY"],"gpt_icon":0},{"id":"2529200803","title":"Sanofi Should Report Lower Profit, Sales Amid U.S. Policy Uncertainty -- Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2529200803","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529200803?lang=en_us&edition=fundamental","pubTime":"2025-04-22 18:07","pubTimestamp":1745316420,"startTime":"0","endTime":"0","summary":"Sanofi is scheduled to report results for the first quarter on Thursday. Here is what you need to know.--U.S. FDA Delays: Sanofi is potentially exposed to any delays in reviews due to recently announced staff firings at the U.S. Food and Drug Administration. Its anti-inflammatory drug Dupixent was scheduled for review in April, and its multiple sclerosis drug tolebrutinib in September, UBS analysts said in a note.--Broader uncertainty in the U.S.: \"In addition to tariffs, where uncertainty is weighing on the whole sector, the group is heavily exposed to vaccines, with all of the risk that might come from more high profile vaccine sceptic discussions in the U.S.,\" UBS analysts said. Despite recent policy noise amid the appointment of vaccine sceptic Robert F. Kennedy Jr. as the head of the Department of Health and Human Services, Sanofi said its vaccination strategy remains unchanged and confirmed that it's on track with manufacturing preparations for the upcoming season, Barclays analy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Sanofi Should Report Lower Profit, Sales Amid U.S. Policy Uncertainty -- Earnings Preview","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY","SNYNF"],"gpt_icon":0},{"id":"2529150843","title":"Sanofi SA  expected to post earnings of 95 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2529150843","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529150843?lang=en_us&edition=fundamental","pubTime":"2025-04-22 13:32","pubTimestamp":1745299933,"startTime":"0","endTime":"0","summary":"Sanofi SA  expected to post earnings of95cents a share - Earnings Preview Sanofi SA SNY.OQ, SNY.O is expected to show a fall in quarterly revenue when it reports  results on April 24 for the period en","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nL8N3R0040:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"gpt_icon":0},{"id":"2529033021","title":"Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2529033021","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529033021?lang=en_us&edition=fundamental","pubTime":"2025-04-22 04:05","pubTimestamp":1745265900,"startTime":"0","endTime":"0","summary":"Believes Company’s Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients. In Deep Track’s View, Properly Focusing on Heplisav Could Result in More than $1 Billion in Cash Generation by 2030 – More than Dynavax’s Current Enterprise Value. Sees Shareholder Representation on Board as Necessary to Restore Investor Confidence in Dynavax and Prevent Strategic Blunders. GREENWICH, Conn., April 21, 2025----Deep Track Capital, LP, , one of the largest shareholders of Dynavax Technologies Corporation  , with ownership of approximately 14.53% of the Company’s outstanding shares, today announced that it has filed a definitive proxy statement in connection with its nomination of four highly qualified candidates for election to the Company’s Board of Directors  at the 2025 Annual Meeting of Stockholders . Deep Track also sent a letter to shareholders.We are not a typical \"activist\" investor. We are a long","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/deep-track-capital-files-definitive-200500490.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4551","USAW.SI","IE00BFXG1179.USD","MRNA","QLD","TQQQ","BK4516","BK4568","BK4596","BK4139","BK4595","PSQ","NVIW.SI","SNY","DVAX","BK4534","TSYW.SI","BK4023","QID","BK4600","BK4585","USJW.SI","BK4533","GBT","BK4548","BK4501","BK4007","NQmain","TARS","SQQQ","STRK","BK4532","BK4588","MNQmain",".IXIC"],"gpt_icon":1},{"id":"2529389778","title":"Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria","url":"https://stock-news.laohu8.com/highlight/detail?id=2529389778","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529389778?lang=en_us&edition=fundamental","pubTime":"2025-04-21 21:22","pubTimestamp":1745241720,"startTime":"0","endTime":"0","summary":"Sanofi SNY and partner Regeneron REGN announced that the FDA approved Dupixent  for the treatment of chronic spontaneous urticaria  in adults and adolescents aged 12 years and above, who remain symptomatic despite histamine-1  antihistamine treatment.Following the latest FDA nod, Dupixent became the first new targeted therapy to be approved for CSU in more than a decade. The drug is now approved for seven type II inflammatory diseases in the United States.Dupixent is already approved in several countries, including the United States and the European Union, for treating severe chronic rhinosinusitis with nasal polyposis, severe asthma, moderate-to-severe atopic dermatitis, eosinophilic esophagitis, prurigo nodularis and chronic obstructive pulmonary disease.CSU is an inflammatory skin condition, primarily occurring due to type 2 inflammation. This causes sudden and debilitating hives and swelling on the skin, which is mostly inadequately controlled by antihistamine treatment.Year to dat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sanofi-regenerons-dupixent-receives-fda-132200561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2237438978.USD","LU2089984988.USD","KRYS","LU2362541273.HKD","LU0053666078.USD","BK4139","BK4588","LU0320765992.SGD","LU0058720904.USD","SNYNF","SNY","LU1917777945.USD","BK4007","LU2362540622.SGD","LU2468319806.SGD","BK4585","IE00BN0W2V16.EUR","JAZZ","LU0114720955.EUR","LU0109394709.USD","LU1974910355.USD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4532","LU2023250504.SGD","LU2106854487.HKD","LU2362541513.USD","BK4533","LU0889565916.HKD","LU0289739699.SGD","LU0882574055.USD","IE00BFXG1179.USD","LU0823416689.USD","REGN"],"gpt_icon":0},{"id":"2529549871","title":"FDA Approves Dupixent for Chronic Hives in Patients Unresponsive to Antihistamines","url":"https://stock-news.laohu8.com/highlight/detail?id=2529549871","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529549871?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:42","pubTimestamp":1745232126,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  and Sanofi  said Friday the FDA approved Dupixent for treating chronic spontaneous urticaria in individuals aged 12 and up who continue to experience symptoms despite antihistamine use.The approval follows phase 3 trials in which Dupixent, used alongside antihistamines, led to greater reductions in itching and hive activity compared to placebo, the companies said.Patients given Dupixent were also more likely to achieve full or near-complete control of their condition after 24 weeks, Regeneron said.The companies added that the reported side effects were consistent with the drug's existing safety profile, with injection site reactions being the most frequent.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2362540622.SGD","LU2023250504.SGD","LU0823416689.USD","LU2089984988.USD","BK4585","LU0114720955.EUR","LU2468319806.SGD","IE00BFXG1179.USD","BK4139","LU2362541273.HKD","LU0058720904.USD","LU2237438978.USD","LU2362541513.USD","LU1917777945.USD","LU1974910355.USD","BK4007","SNY","LU0889565916.HKD","REGN","LU0289739699.SGD","LU2106854487.HKD","LU0053666078.USD","LU0109394709.USD","LU0882574055.USD","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2528963660","title":"Regeneron, Sanofi Get FDA Approval For Dupixent in Skin Disease CSU","url":"https://stock-news.laohu8.com/highlight/detail?id=2528963660","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528963660?lang=en_us&edition=fundamental","pubTime":"2025-04-18 23:34","pubTimestamp":1744990440,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals and Sanofi won U.S. Food and Drug Administration expanded approval of their blockbuster anti-inflammatory drug Dupixent for the inflammatory skin condition chronic spontaneous urticaria, or CSU.Regeneron and Sanofi on Friday said the approval covers Dupixent in people 12 and older who have CSU and remain symptomatic despite histamine-1 antihistamine treatment.The companies said the green light makes Dupixent the first targeted therapy for CSU in more than a decade, adding that CSU is the seventh disease with underlying type 2 inflammation for which Dupixent is approved.Tarrytown, N.Y., biotechnology company Regeneron created Dupixent and markets it jointly in the U.S. with France's Sanofi under a 2007 collaboration agreement, while Sanofi markets the drug internationally. Dupixent global net sales topped $14 billion last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1917777945.USD","SNY","LU0289739699.SGD","LU0823416689.USD","LU0053666078.USD","LU0320765992.SGD","LU2089984988.USD","SNYNF","LU2362541273.HKD","LU0058720904.USD","LU2106854487.HKD","REGN","LU0882574055.USD","BK4139","LU2468319806.SGD","LU0109394709.USD","BK4007","LU2362540622.SGD","LU2237438978.USD","IE00BFXG1179.USD","BK4588","LU0114720955.EUR","LU0889565916.HKD","LU2362541513.USD","LU2023250504.SGD","LU1974910355.USD","BK4585"],"gpt_icon":0},{"id":"2528096277","title":"Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria","url":"https://stock-news.laohu8.com/highlight/detail?id=2528096277","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528096277?lang=en_us&edition=fundamental","pubTime":"2025-04-18 23:15","pubTimestamp":1744989300,"startTime":"0","endTime":"0","summary":"Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria. Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and hives compared to placebo. In the US, there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite antihistamine treatment. CSU is the seventh disease with underlying type 2 inflammation in which Dupixent is approved. Paris and Tarrytown, NY, April 18, 2025. The US Food and Drug Administration  has approved Dupixent  for the treatment of adults and adolescents aged 12 years and older with chronic spontaneous urticaria  who remain symptomatic despite histamine-1  antihistamine treatment.Kenneth MendezPresident and Chief Executive Officer at the Asthma and Allergy Foundation of America“People with chronic spontaneous urticaria experience sudden, unpredictable hives and severe itch that cause a significant, and often overwhelming,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/press-release-dupixent-approved-us-151500435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2362540622.SGD","BK4585","LU0889565916.HKD","LU2023250504.SGD","LU0882574055.USD","LU2362541513.USD","LU2106854487.HKD","LU0109394709.USD","SNY","LU0053666078.USD","LU0823416689.USD","IE00BFXG1179.USD","LU0058720904.USD","BK4007","LU2468319806.SGD","REGN","LU0289739699.SGD","LU0114720955.EUR","LU1917777945.USD","LU2362541273.HKD","LU2089984988.USD","BK4588","BK4139","LU2237438978.USD","LU1974910355.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2528096229","title":"Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528096229","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528096229?lang=en_us&edition=fundamental","pubTime":"2025-04-18 23:15","pubTimestamp":1744989300,"startTime":"0","endTime":"0","summary":"Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo. In the U.S., there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite antihistamine treatment. CSU is the seventh disease with underlying type 2 inflammation in which Dupixent is approved. The U.S. approval is based on data from two Phase 3 clinical trials, Study A  and Study C , which included biologic-nave patients aged 12 years and older who were symptomatic despite the use of antihistamines and assessed Dupixent as an add-on therapy to standard-of-care antihistamines, compared to antihistamines alone. Both trials met their primary and key secondary endpoints with Dupixent demonstrating reductions in itch severity and urticaria activity  compared to placebo at 24 weeks. Dupixent also increased the likelihood of well-controlled disease or complete response compared to placebo at 24 weeks. Study B  provided a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dupixent-dupilumab-approved-u-first-151500962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFXG1179.USD","LU1974910355.USD","SNY","LU1917777945.USD","BK4585","LU2362541273.HKD","LU0109394709.USD","LU2089984988.USD","LU2362541513.USD","LU2468319806.SGD","BK4139","BK4588","BK4007","PN","REGN","BK4096","LU0053666078.USD","LU0320765992.SGD","UAE","LU2237438978.USD","LU0882574055.USD","LU0114720955.EUR","LU0823416689.USD","LU0289739699.SGD","LU2023250504.SGD","LU2106854487.HKD","LU2362540622.SGD","LU0889565916.HKD","LU0058720904.USD"],"gpt_icon":0},{"id":"2528448647","title":"Sanofi, Earendil Labs Sign Licensing Deal for Autoimmune, Inflammatory Bowel Disease Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2528448647","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528448647?lang=en_us&edition=fundamental","pubTime":"2025-04-17 22:46","pubTimestamp":1744901160,"startTime":"0","endTime":"0","summary":"Sanofi  and Earendil Labs have signed a licensing deal for two bispecific antibodies that target autoimmune and inflammatory bowel diseases, Earendil Labs said in a statement Thursday.Sanofi will gain exclusive global rights to drug candidates HXN-1002 and HXN-1003 once the deal closes, according to the statement.Earendil will receive an upfront payment of $125 million from Sanofi, it added.Earendil could earn up to $1.72 billion in development and commercial milestones, including a $50 million payment expected soon after closing, Earendil Labs said.Earendil is also eligible for tiered sales royalties that start in the high single digits and rise to the low double digits, the statement added.Sanofi's shares were up about 1.6% in recent trading.Price: 51.35, Change: +0.79, Percent Change: +1.56","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SNYNF","SNY","BK4585","BK4588","IE00BFXG1179.USD","BK4007"],"gpt_icon":0},{"id":"2528474479","title":"Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2528474479","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528474479?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:15","pubTimestamp":1744895700,"startTime":"0","endTime":"0","summary":"J&J JNJ began the earnings season for the drug and biotech sector this week. Pfizer PFE announced the discontinuation of its danuglipron weight loss pill program. The European Commission granted marketing authorization for the expanded use of Roche’s RHHBY cancer drug, Columvi. Sanofi SNY provided an update on its respiratory pipeline.Here's a recap of the week’s most important stories.J&J beat first-quarter estimates for both earnings and sales. Adjusted earnings of $2.77 per share rose 2.2% from the year-ago period. Sales of $21.89 billion rose 2.4% from the year-ago quarter. Innovative Medicines segment sales rose 2.3% year over year to $13.87 billion. MedTech segment sales came in at $8.02 billion, up 2.5% from the year-ago period.The U.S. Centers for Disease Control and Prevention’s  Advisory Committee on Immunization Practices recommended the expanded use of Pfizer and GSK’s respiratory syncytial virus  vaccines, Abrysvo and Arexvy, respectively, in adults aged 50 to 59 at increa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-j-js-131500764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["JNJ","LU2505996509.AUD","LU0795875169.SGD","LU2430703095.HKD","SGXZ57979304.SGD","SG9999001440.SGD","BK4568","LU1162221912.USD","CDC","IE00BFXG1179.USD","LU1244550221.USD","PFE","IE00B19Z3581.USD","03165","LU1066051225.USD","LU0058720904.USD","LU2430703178.SGD","IE00BGHQF631.EUR","LU0985320562.USD","LU1244550494.USD","IE00BVYPNV92.GBP","LU1718418525.SGD","IE00BDGV0183.EUR","LU1032466523.USD","LU0985481810.HKD","LU2129689605.HKD","IE00BSNM7G36.USD","SG9999013999.USD","LU0170899867.USD","IE00BN8TJ469.HKD","IE00B19Z3B42.SGD","SNY","SG9999001176.USD","LU0122379950.USD","IE0002141913.USD","BK4581","IE00BFTCPJ56.SGD","LU1778281490.HKD","RHHBY","IE00BBT3K403.USD","LU0345769128.USD","LU0792757196.USD","LU0098860793.USD","LU1066051811.HKD","LU1585245621.USD","LU2347655156.SGD","SG9999003800.SGD","LU2430703251.USD","LU0203345920.USD","BK4550"],"gpt_icon":1},{"id":"2527188664","title":"Chrissy Teigen - author, entrepreneur, mom to young son with type 1 diabetes - joins Sanofi's Screen For Type 1 movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2527188664","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527188664?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:00","pubTimestamp":1744718400,"startTime":"0","endTime":"0","summary":"Teigen to advocate for the importance of type 1 diabetes screening after son's diagnosis was uncovered during an unexpected medical emergency. Screen For Type 1 movement continues momentum into year two with the goal of encouraging people to screen early; just one blood test can spot type 1 diabetes before symptoms occur. MORRISTOWN, N.J., April 15, 2025 /PRNewswire/ -- Sanofi, a leader in diabetes care, welcomes author, entrepreneur, and mom Chrissy Teigen as its new celebrity spokesperson for the Screen For Type 1 movement. The partnership, announced on T1D Day, comes as the Screen For Type 1 movement strives to expand diabetes education nationwide, raising awareness of the benefits of early risk detection.Anyone can screen for type 1 diabetes, which consists of just one blood test that identifies whether a person has autoantibodies related to type 1 diabetes before symptoms even appear. While type 1 diabetes cannot be prevented, it can be detected early through autoantibody screenin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/chrissy-teigen-author-entrepreneur-mom-120000190.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/chrissy-teigen-author-entrepreneur-mom-120000190.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SNYNF","IE00BFXG1179.USD","SNY","BK4585","BK4588","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNY\",params:#limit:5,,,undefined,":[{"date":"2025-05-09","symbol":"SNY","amount":2.212154,"announcedDate":"2025-04-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-09","defaultRemindTime":1746797400000,"name":"赛诺菲安万特","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-12","payableDate":"2025-05-09","currency":"USD","dateTimestamp":1746763200000,"payDate":"2025-06-12"},{"market":"US","date":"2025-04-24","symbol":"SNY","fiscalQuarterEnding":"2025/03","expectedEps":0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745467200000,"reportTimeType":"pre","actualEps":0.94},{"market":"US","date":"2025-01-30","symbol":"SNY","fiscalQuarterEnding":"2024/12","expectedEps":0.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738213200000,"reportTimeType":"pre","actualEps":0.7},{"market":"US","date":"2024-10-25","symbol":"SNY","fiscalQuarterEnding":"2024/09","expectedEps":1.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1729828800000,"reportTimeType":"pre","actualEps":1.57},{"date":"2024-09-12","symbol":"SNY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1726128000000,"name":null,"time":"Pre-Market","dateTimestamp":1726113600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNY\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-06","recordDate":"2015-05-08","paymentDate":"2015-06-02","value":1.086507,"currency":"USD"},{"executeDate":"2016-05-05","recordDate":"2016-05-09","paymentDate":"2016-06-01","value":1.124297,"currency":"USD"},{"executeDate":"2017-05-11","recordDate":"2017-05-15","paymentDate":"2017-06-07","value":1.053962,"currency":"USD"},{"executeDate":"2018-05-09","recordDate":"2018-05-10","paymentDate":"2018-06-04","value":1.252612,"currency":"USD"},{"executeDate":"2019-05-07","recordDate":"2019-05-08","paymentDate":"2019-05-31","value":1.739462,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.2857,"hold":0.2857,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1742616000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SNY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SNY","date":"2025-04-29","current":18.310973,"percent":0.585106,"low":7.700371,"twenty":10.042807,"median":17.659092,"eighty":24.145603,"high":35.240461,"avg":17.744611,"sd":6.880942,"marketCap":131487479602.14},"quantilePoints":[{"date":"2020-05-01","current":33.287209,"twenty":10.936939,"median":22.288206,"eighty":27.915788,"marketCap":122748871163.92},{"date":"2020-05-08","current":33.429348,"twenty":10.947749,"median":22.313398,"eighty":28.361828,"marketCap":121627238914.58},{"date":"2020-05-15","current":32.595691,"twenty":10.949613,"median":22.330456,"eighty":28.489712,"marketCap":118247569927.49},{"date":"2020-05-22","current":32.461152,"twenty":10.950809,"median":22.368981,"eighty":28.664689,"marketCap":118529173787.58},{"date":"2020-05-29","current":32.711543,"twenty":10.957417,"median":22.45326,"eighty":28.739014,"marketCap":121900047291.83},{"date":"2020-06-05","current":33.320704,"twenty":10.961705,"median":22.504413,"eighty":28.869762,"marketCap":126404479866.46},{"date":"2020-06-12","current":33.26848,"twenty":10.97427,"median":22.552737,"eighty":29.165734,"marketCap":125312894610.63},{"date":"2020-06-19","current":35.174448,"twenty":10.980961,"median":22.560851,"eighty":29.253683,"marketCap":131987852645.25},{"date":"2020-06-26","current":34.045816,"twenty":10.987268,"median":22.616571,"eighty":29.711727,"marketCap":127924643785.45},{"date":"2020-07-02","current":34.367214,"twenty":10.994274,"median":22.648355,"eighty":29.771242,"marketCap":129509727296.23},{"date":"2020-07-10","current":33.233448,"twenty":10.9995,"median":22.663506,"eighty":32.384166,"marketCap":126030678803.03},{"date":"2020-07-17","current":34.840553,"twenty":11.002375,"median":22.680357,"eighty":32.642032,"marketCap":133469182626.29},{"date":"2020-07-24","current":33.192336,"twenty":11.004309,"median":22.714228,"eighty":32.855777,"marketCap":129403011819.03},{"date":"2020-07-31","current":10.079688,"twenty":10.9995,"median":22.705861,"eighty":32.972702,"marketCap":131609513547.85},{"date":"2020-08-07","current":9.946507,"twenty":10.971294,"median":22.66842,"eighty":32.855777,"marketCap":129396034746.58},{"date":"2020-08-14","current":9.727952,"twenty":10.948867,"median":22.658549,"eighty":32.749663,"marketCap":127031956635.12},{"date":"2020-08-21","current":9.828123,"twenty":10.929747,"median":22.644775,"eighty":32.720989,"marketCap":127780651499.59},{"date":"2020-08-28","current":9.679005,"twenty":10.883242,"median":22.578254,"eighty":32.71485,"marketCap":127069323852.74},{"date":"2020-09-04","current":9.512813,"twenty":10.85502,"median":22.559456,"eighty":32.642032,"marketCap":123841606541.64},{"date":"2020-09-11","current":9.96472,"twenty":10.823199,"median":22.547298,"eighty":32.561309,"marketCap":130185382800.66},{"date":"2020-09-18","current":10.067167,"twenty":10.684765,"median":22.493564,"eighty":32.490302,"marketCap":131820291420.1},{"date":"2020-09-25","current":9.858857,"twenty":10.595525,"median":22.444418,"eighty":32.458162,"marketCap":126422921729.99},{"date":"2020-10-02","current":9.798527,"twenty":10.526117,"median":22.342652,"eighty":32.407337,"marketCap":126679565248.92},{"date":"2020-10-09","current":9.824708,"twenty":10.410161,"median":22.324584,"eighty":32.285505,"marketCap":128128683268.34},{"date":"2020-10-16","current":9.793052,"twenty":10.315413,"median":22.302943,"eighty":31.257628,"marketCap":126623612278.58},{"date":"2020-10-23","current":9.441308,"twenty":10.238589,"median":22.261435,"eighty":29.811136,"marketCap":123347203619.79},{"date":"2020-10-30","current":8.661295,"twenty":10.199611,"median":22.234806,"eighty":29.773341,"marketCap":113280166110.01},{"date":"2020-11-06","current":9.327376,"twenty":10.132097,"median":22.205679,"eighty":29.767042,"marketCap":124442629581.55},{"date":"2020-11-13","current":9.605003,"twenty":10.089923,"median":22.112471,"eighty":29.762798,"marketCap":127479835927.15},{"date":"2020-11-20","current":9.6106,"twenty":10.079688,"median":22.081393,"eighty":29.73408,"marketCap":127917182157.26},{"date":"2020-11-27","current":9.538955,"twenty":10.057978,"median":22.005256,"eighty":29.655002,"marketCap":127995801275.71},{"date":"2020-12-04","current":9.358721,"twenty":10.040076,"median":21.945075,"eighty":29.437865,"marketCap":127467141893.2},{"date":"2020-12-11","current":8.790033,"twenty":10.022546,"median":21.91943,"eighty":29.296005,"marketCap":119489512407.95},{"date":"2020-12-18","current":8.844887,"twenty":9.993694,"median":21.901999,"eighty":29.279125,"marketCap":121396802063.1},{"date":"2020-12-24","current":8.769883,"twenty":9.976103,"median":21.881466,"eighty":29.245202,"marketCap":119941986349.01},{"date":"2020-12-31","current":8.810183,"twenty":9.961936,"median":21.873052,"eighty":29.24273,"marketCap":120950078152.91},{"date":"2021-01-08","current":8.820259,"twenty":9.95106,"median":21.862976,"eighty":29.210969,"marketCap":121221849881.21},{"date":"2021-01-15","current":9.126992,"twenty":9.936588,"median":21.828735,"eighty":29.197581,"marketCap":123845036018.62},{"date":"2021-01-22","current":9.119156,"twenty":9.919292,"median":21.813001,"eighty":29.173346,"marketCap":124582207014},{"date":"2021-01-29","current":8.636715,"twenty":9.906894,"median":21.809329,"eighty":29.059102,"marketCap":117661873131.83},{"date":"2021-02-05","current":8.176599,"twenty":9.88162,"median":21.779975,"eighty":28.982923,"marketCap":120922774999.4},{"date":"2021-02-12","current":7.987538,"twenty":9.856239,"median":21.763827,"eighty":28.950951,"marketCap":119014418424.43},{"date":"2021-02-19","current":7.870014,"twenty":9.848372,"median":21.763595,"eighty":28.901957,"marketCap":117391358460.33},{"date":"2021-02-26","current":7.746359,"twenty":9.840411,"median":21.746147,"eighty":28.832667,"marketCap":115225330598.91},{"date":"2021-03-05","current":7.860937,"twenty":9.827943,"median":21.729717,"eighty":28.787173,"marketCap":115132662522.04},{"date":"2021-03-12","current":8.118972,"twenty":9.808685,"median":21.685029,"eighty":28.757776,"marketCap":119210132761.26},{"date":"2021-03-19","current":8.502978,"twenty":9.798186,"median":21.612115,"eighty":28.742096,"marketCap":124417528040.94},{"date":"2021-03-26","current":8.489771,"twenty":9.792219,"median":21.598158,"eighty":28.727957,"marketCap":123096173961.55},{"date":"2021-04-01","current":8.553964,"twenty":9.788159,"median":21.54258,"eighty":28.711437,"marketCap":123735063715.73},{"date":"2021-04-09","current":8.641332,"twenty":9.782356,"median":21.526019,"eighty":28.694903,"marketCap":126246626546.64},{"date":"2021-04-16","current":8.636253,"twenty":9.769654,"median":21.512492,"eighty":28.66049,"marketCap":127185060180.88},{"date":"2021-04-23","current":8.669778,"twenty":9.761091,"median":21.479045,"eighty":28.625112,"marketCap":128556561372.57},{"date":"2021-04-30","current":8.936356,"twenty":9.755206,"median":21.457669,"eighty":28.539275,"marketCap":131116008424.15},{"date":"2021-05-07","current":8.761308,"twenty":9.751942,"median":21.433287,"eighty":28.492512,"marketCap":129875631253.04},{"date":"2021-05-14","current":8.892563,"twenty":9.741584,"median":21.426198,"eighty":28.475014,"marketCap":131645337996.12},{"date":"2021-05-21","current":9.047404,"twenty":9.729833,"median":21.41999,"eighty":28.415141,"marketCap":134492606805.61},{"date":"2021-05-28","current":9.019717,"twenty":9.710422,"median":21.40835,"eighty":28.40452,"marketCap":134081034734.92},{"date":"2021-06-04","current":8.826935,"twenty":9.707463,"median":21.392314,"eighty":28.379325,"marketCap":130991765454.43},{"date":"2021-06-11","current":9.116284,"twenty":9.694395,"median":21.363939,"eighty":28.361828,"marketCap":134500207706.54},{"date":"2021-06-18","current":9.021943,"twenty":9.679005,"median":21.290156,"eighty":28.230746,"marketCap":130457184786.01},{"date":"2021-06-25","current":9.04963,"twenty":9.672117,"median":21.229467,"eighty":28.073267,"marketCap":131826509965.36},{"date":"2021-07-02","current":9.013739,"twenty":9.660792,"median":21.196129,"eighty":27.996278,"marketCap":130199639608.01},{"date":"2021-07-09","current":8.944008,"twenty":9.658829,"median":21.16444,"eighty":27.931886,"marketCap":129422313900.82},{"date":"2021-07-16","current":9.010663,"twenty":9.638085,"median":21.140332,"eighty":27.848598,"marketCap":129770992211.6},{"date":"2021-07-23","current":9.031172,"twenty":9.62122,"median":21.117164,"eighty":27.80391,"marketCap":129576758627.22},{"date":"2021-07-30","current":18.87536,"twenty":9.610467,"median":21.085355,"eighty":27.796937,"marketCap":129351074870.7},{"date":"2021-08-06","current":18.73975,"twenty":9.613461,"median":21.013453,"eighty":27.749237,"marketCap":127349176618.04},{"date":"2021-08-13","current":19.000477,"twenty":9.62122,"median":20.964049,"eighty":27.709316,"marketCap":129532398703.09},{"date":"2021-08-20","current":19.713131,"twenty":9.626758,"median":20.922915,"eighty":27.702194,"marketCap":133040601577.1},{"date":"2021-08-27","current":19.159086,"twenty":9.631579,"median":20.849323,"eighty":27.682689,"marketCap":130505881690.84},{"date":"2021-09-03","current":19.087386,"twenty":9.636484,"median":20.812207,"eighty":27.640133,"marketCap":131037228600.12},{"date":"2021-09-10","current":17.788527,"twenty":9.637931,"median":20.810313,"eighty":27.621196,"marketCap":121557039339.96},{"date":"2021-09-17","current":17.718998,"twenty":9.644258,"median":20.781658,"eighty":27.597623,"marketCap":120158061709.12},{"date":"2021-09-24","current":17.821119,"twenty":9.653374,"median":20.756596,"eighty":27.571856,"marketCap":120553399377.05},{"date":"2021-10-01","current":17.949313,"twenty":9.657986,"median":20.686673,"eighty":27.533829,"marketCap":120210038226.29},{"date":"2021-10-08","current":18.316512,"twenty":9.65882,"median":20.60166,"eighty":27.49647,"marketCap":122456300914.25},{"date":"2021-10-15","current":18.21668,"twenty":9.659965,"median":20.367209,"eighty":27.481537,"marketCap":122085570969.84},{"date":"2021-10-22","current":18.492625,"twenty":9.660762,"median":19.534967,"eighty":27.418547,"marketCap":124266480579.27},{"date":"2021-10-29","current":17.57188,"twenty":9.660792,"median":19.400258,"eighty":27.363912,"marketCap":125449567069.84},{"date":"2021-11-05","current":17.984594,"twenty":9.662246,"median":19.19059,"eighty":27.343794,"marketCap":128307008370.7},{"date":"2021-11-12","current":18.139856,"twenty":9.664147,"median":19.148222,"eighty":27.315537,"marketCap":128214619445.91},{"date":"2021-11-19","current":18.074795,"twenty":9.669177,"median":19.129754,"eighty":27.3008,"marketCap":126337351612.14},{"date":"2021-11-26","current":17.283895,"twenty":9.672117,"median":19.062399,"eighty":27.290992,"marketCap":120754520924.52},{"date":"2021-12-03","current":17.031784,"twenty":9.672185,"median":18.974404,"eighty":27.274231,"marketCap":118697631154.76},{"date":"2021-12-10","current":17.593219,"twenty":9.673996,"median":18.883829,"eighty":27.261649,"marketCap":122887806332.16},{"date":"2021-12-17","current":17.666414,"twenty":9.676585,"median":18.822313,"eighty":27.226753,"marketCap":122981663791.86},{"date":"2021-12-23","current":17.924629,"twenty":9.677102,"median":18.797147,"eighty":27.187184,"marketCap":125231028798.23},{"date":"2021-12-31","current":18.010023,"twenty":9.680432,"median":18.68789,"eighty":27.152672,"marketCap":126457276638.23},{"date":"2022-01-07","current":18.01409,"twenty":9.687791,"median":18.583882,"eighty":27.099359,"marketCap":126127227506.24},{"date":"2022-01-14","current":18.425049,"twenty":9.694395,"median":18.458837,"eighty":27.042911,"marketCap":129932901404.91},{"date":"2022-01-21","current":18.490113,"twenty":9.694395,"median":18.493429,"eighty":27.028616,"marketCap":129474826588.41},{"date":"2022-01-28","current":19.165142,"twenty":9.694395,"median":18.494232,"eighty":27.028595,"marketCap":132074546389.11},{"date":"2022-02-04","current":18.213402,"twenty":9.69608,"median":18.572578,"eighty":27.025402,"marketCap":129696764676.74},{"date":"2022-02-11","current":18.927495,"twenty":9.697119,"median":18.616113,"eighty":27.010232,"marketCap":134335997389.37},{"date":"2022-02-18","current":18.766118,"twenty":9.697119,"median":18.604323,"eighty":27.010232,"marketCap":132345369395.97},{"date":"2022-02-25","current":18.833821,"twenty":9.697119,"median":18.575534,"eighty":27.010232,"marketCap":132044689275.57},{"date":"2022-03-04","current":17.617959,"twenty":9.697119,"median":18.491369,"eighty":27.010232,"marketCap":119664437682.82},{"date":"2022-03-11","current":18.783661,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":127973204254.43},{"date":"2022-03-18","current":18.717451,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":128848117335.18},{"date":"2022-03-25","current":18.683343,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":127751282161.3},{"date":"2022-04-01","current":18.889374,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":129744565958.06},{"date":"2022-04-08","current":20.960102,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":141869390625.41},{"date":"2022-04-14","current":20.695242,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":139183497682.91},{"date":"2022-04-22","current":20.346108,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":136481434838.85},{"date":"2022-04-29","current":18.952765,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":133142723720.1},{"date":"2022-05-06","current":18.179144,"twenty":9.697119,"median":18.493429,"eighty":27.010232,"marketCap":128384549744.68},{"date":"2022-05-13","current":18.692394,"twenty":9.697119,"median":18.527753,"eighty":27.010232,"marketCap":129700736023.73},{"date":"2022-05-20","current":19.16256,"twenty":9.697119,"median":18.604323,"eighty":27.010232,"marketCap":134758546837.22},{"date":"2022-05-27","current":19.177546,"twenty":9.697119,"median":18.665261,"eighty":27.010232,"marketCap":136958987699.81},{"date":"2022-06-03","current":18.744225,"twenty":9.697119,"median":18.681313,"eighty":27.010232,"marketCap":133921762001.07},{"date":"2022-06-10","current":18.146643,"twenty":9.697119,"median":18.685349,"eighty":27.010232,"marketCap":127291929717.98},{"date":"2022-06-17","current":17.640852,"twenty":9.697119,"median":18.685349,"eighty":27.010232,"marketCap":123044805550.91},{"date":"2022-06-24","current":18.83789,"twenty":9.696859,"median":18.692394,"eighty":27.014025,"marketCap":132461365342.83},{"date":"2022-07-01","current":18.293193,"twenty":9.696859,"median":18.693435,"eighty":27.014025,"marketCap":126838383992.09},{"date":"2022-07-08","current":18.63272,"twenty":9.696859,"median":18.693435,"eighty":27.014025,"marketCap":126418025181.68},{"date":"2022-07-15","current":18.795918,"twenty":9.696859,"median":18.717451,"eighty":27.014025,"marketCap":126431471445.01},{"date":"2022-07-22","current":18.263208,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":124455681540.58},{"date":"2022-07-29","current":18.321107,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":124140260314.16},{"date":"2022-08-05","current":18.377647,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":123992191551.9},{"date":"2022-08-12","current":16.132936,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":109885258896.75},{"date":"2022-08-19","current":15.415581,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102816971778.11},{"date":"2022-08-26","current":15.459,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102642813930.03},{"date":"2022-09-02","current":15.37405,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102457677511.04},{"date":"2022-09-09","current":15.328743,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102237792167.67},{"date":"2022-09-16","current":15.453336,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102882856127.48},{"date":"2022-09-23","current":14.877565,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":96093011237.72},{"date":"2022-09-30","current":14.800166,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":96408611153.17},{"date":"2022-10-07","current":15.132414,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":98274151179.98},{"date":"2022-10-14","current":15.398591,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":99690906745.93},{"date":"2022-10-21","current":15.398591,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":100326441165.16},{"date":"2022-10-28","current":16.846401,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":107356651323.46},{"date":"2022-11-04","current":17.17473,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":109112652999.6},{"date":"2022-11-11","current":16.109615,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":106637600025.82},{"date":"2022-11-18","current":16.83559,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":111812739546.11},{"date":"2022-11-25","current":17.129097,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":114152420880.73},{"date":"2022-12-02","current":16.782758,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":112782528627.45},{"date":"2022-12-09","current":17.361946,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":117264953276.43},{"date":"2022-12-16","current":17.144751,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":116510134592.3},{"date":"2022-12-23","current":17.802208,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":121183588329.26},{"date":"2022-12-30","current":17.579142,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":120406882967.83},{"date":"2023-01-06","current":17.829602,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":121279894677.35},{"date":"2023-01-13","current":17.841342,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":123710007946.55},{"date":"2023-01-20","current":17.659092,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":122645342505.42},{"date":"2023-01-27","current":17.429425,"twenty":9.703429,"median":18.719457,"eighty":27.014025,"marketCap":121260511615.28},{"date":"2023-02-03","current":12.687149,"twenty":9.709538,"median":18.719457,"eighty":27.014025,"marketCap":115251355422.68},{"date":"2023-02-10","current":13.217643,"twenty":9.726396,"median":18.719457,"eighty":27.014025,"marketCap":118159855219.99},{"date":"2023-02-17","current":13.277249,"twenty":9.741642,"median":18.719457,"eighty":27.014025,"marketCap":118515515804.01},{"date":"2023-02-24","current":13.411211,"twenty":9.752083,"median":18.719457,"eighty":27.014025,"marketCap":118448244308.93},{"date":"2023-03-03","current":13.302322,"twenty":9.756767,"median":18.719457,"eighty":27.014025,"marketCap":118034490740.94},{"date":"2023-03-10","current":13.357512,"twenty":9.764714,"median":18.719457,"eighty":27.014025,"marketCap":119257397037.12},{"date":"2023-03-17","current":13.394803,"twenty":9.773462,"median":18.719457,"eighty":27.014025,"marketCap":119526591543.55},{"date":"2023-03-24","current":14.48369,"twenty":9.785178,"median":18.719457,"eighty":27.014025,"marketCap":130424881067.13},{"date":"2023-03-31","current":14.952061,"twenty":9.790694,"median":18.718645,"eighty":27.010232,"marketCap":135988374469.8},{"date":"2023-04-06","current":15.280218,"twenty":9.798413,"median":18.718645,"eighty":27.010232,"marketCap":139686260171.45},{"date":"2023-04-14","current":15.221476,"twenty":9.80991,"median":18.730688,"eighty":27.025402,"marketCap":140825574178.82},{"date":"2023-04-19","current":15.209543,"twenty":9.82744,"median":18.731112,"eighty":27.026041,"marketCap":139558349488.11},{"date":"2023-04-27","current":15.21474,"twenty":9.850092,"median":18.73173,"eighty":27.027318,"marketCap":140140612943.9},{"date":"2023-05-05","current":15.175888,"twenty":9.902113,"median":18.731826,"eighty":27.028595,"marketCap":139552044885.56},{"date":"2023-05-12","current":14.838181,"twenty":9.939677,"median":18.731826,"eighty":27.028595,"marketCap":135403671391.13},{"date":"2023-05-19","current":15.184854,"twenty":9.959028,"median":18.731826,"eighty":27.028595,"marketCap":136642429723.27},{"date":"2023-05-26","current":14.853124,"twenty":9.978835,"median":18.733652,"eighty":27.028599,"marketCap":133126940240.24},{"date":"2023-06-02","current":14.192653,"twenty":10.040758,"median":18.733652,"eighty":27.028599,"marketCap":127343787455.44},{"date":"2023-06-09","current":14.256612,"twenty":10.09699,"median":18.733652,"eighty":27.028599,"marketCap":128372490395.43},{"date":"2023-06-16","current":14.295467,"twenty":10.208772,"median":18.72486,"eighty":27.028599,"marketCap":130508209942.1},{"date":"2023-06-23","current":14.734821,"twenty":10.181908,"median":18.697387,"eighty":27.028603,"marketCap":134961533039.24},{"date":"2023-06-30","current":14.675045,"twenty":10.181908,"median":18.683343,"eighty":27.028603,"marketCap":133521342889.49},{"date":"2023-07-07","current":14.039924,"twenty":10.181908,"median":18.651241,"eighty":27.028603,"marketCap":127451273212.04},{"date":"2023-07-14","current":14.002564,"twenty":10.181908,"median":18.628706,"eighty":27.028603,"marketCap":130982117535.26},{"date":"2023-07-21","current":14.736316,"twenty":10.181908,"median":18.609955,"eighty":27.028603,"marketCap":137261916493.54},{"date":"2023-07-28","current":14.230057,"twenty":10.155044,"median":18.575133,"eighty":27.028608,"marketCap":130696325708.32},{"date":"2023-08-04","current":13.64955,"twenty":10.155044,"median":18.53333,"eighty":27.028608,"marketCap":128783719369.32},{"date":"2023-08-11","current":14.107345,"twenty":10.155044,"median":18.465688,"eighty":27.028608,"marketCap":133909438393.92},{"date":"2023-08-18","current":14.257236,"twenty":10.155044,"median":18.417461,"eighty":27.028608,"marketCap":133639295738.06},{"date":"2023-08-25","current":14.360528,"twenty":10.155044,"median":18.371061,"eighty":27.028608,"marketCap":134024340566.45},{"date":"2023-09-01","current":14.34598,"twenty":10.155044,"median":18.34457,"eighty":27.028608,"marketCap":134077344689.8},{"date":"2023-09-08","current":14.597664,"twenty":10.155044,"median":18.325923,"eighty":27.028608,"marketCap":134604678073.84},{"date":"2023-09-15","current":14.95555,"twenty":10.155044,"median":18.296091,"eighty":27.016307,"marketCap":137463437822.93},{"date":"2023-09-22","current":14.853801,"twenty":10.12818,"median":18.276078,"eighty":27.020855,"marketCap":136484543397.31},{"date":"2023-09-29","current":14.763602,"twenty":10.12818,"median":18.246983,"eighty":26.983029,"marketCap":134423031209.85},{"date":"2023-10-06","current":14.868349,"twenty":10.12818,"median":18.218159,"eighty":26.938973,"marketCap":134892153493.37},{"date":"2023-10-13","current":15.040019,"twenty":10.12818,"median":18.16832,"eighty":26.598464,"marketCap":136737545848.28},{"date":"2023-10-20","current":14.380784,"twenty":10.12818,"median":18.144978,"eighty":26.402781,"marketCap":131062102932.84},{"date":"2023-10-27","current":11.85036,"twenty":10.092665,"median":18.111628,"eighty":26.025777,"marketCap":107534279335.51},{"date":"2023-11-03","current":11.80423,"twenty":10.092665,"median":18.07332,"eighty":25.817137,"marketCap":113606320100.85},{"date":"2023-11-10","current":11.775378,"twenty":10.092665,"median":18.059836,"eighty":25.817137,"marketCap":114360557197.64},{"date":"2023-11-17","current":11.879108,"twenty":10.092665,"median":18.023837,"eighty":25.817137,"marketCap":116984566837.93},{"date":"2023-11-24","current":11.946878,"twenty":10.092665,"median":18.009006,"eighty":25.817137,"marketCap":118113843833.15},{"date":"2023-12-01","current":11.863894,"twenty":10.092665,"median":17.972228,"eighty":25.817137,"marketCap":117306211282.58},{"date":"2023-12-08","current":11.912301,"twenty":10.09699,"median":17.952065,"eighty":25.812238,"marketCap":116514105188.26},{"date":"2023-12-15","current":12.129442,"twenty":10.09699,"median":17.934507,"eighty":25.812238,"marketCap":120907663627.27},{"date":"2023-12-22","current":12.356264,"twenty":10.09699,"median":17.886813,"eighty":25.812238,"marketCap":123141571763.22},{"date":"2023-12-29","current":12.414352,"twenty":10.092665,"median":17.852857,"eighty":25.817137,"marketCap":124666059594.59},{"date":"2024-01-05","current":12.928851,"twenty":10.088339,"median":17.827036,"eighty":25.822036,"marketCap":128452561703.01},{"date":"2024-01-12","current":13.228975,"twenty":10.088339,"median":17.806558,"eighty":25.822036,"marketCap":131304891825.05},{"date":"2024-01-19","current":13.006481,"twenty":10.084014,"median":17.776767,"eighty":25.826935,"marketCap":128114681751.41},{"date":"2024-01-26","current":12.735372,"twenty":10.088339,"median":17.745072,"eighty":25.822036,"marketCap":125131555256.31},{"date":"2024-02-02","current":20.334039,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":119118906599.05},{"date":"2024-02-09","current":20.085581,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":116751493787.94},{"date":"2024-02-16","current":20.076293,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":116634730314.15},{"date":"2024-02-23","current":20.830953,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":121673497945.92},{"date":"2024-03-01","current":20.187328,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":117837605321.59},{"date":"2024-03-08","current":20.275189,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":119656853104.92},{"date":"2024-03-15","current":20.393108,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":119946394721.71},{"date":"2024-03-22","current":20.497155,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":120191807946.57},{"date":"2024-03-28","current":21.03126,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":122670991700.15},{"date":"2024-04-05","current":20.194264,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":118454296559.85},{"date":"2024-04-12","current":19.993107,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":115628981743.6},{"date":"2024-04-19","current":20.090217,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":115682634323.95},{"date":"2024-04-26","current":25.102236,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":122028864510.98},{"date":"2024-05-03","current":25.121496,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":121965711156.52},{"date":"2024-05-10","current":25.955211,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":126909542740.01},{"date":"2024-05-17","current":24.564329,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121166222484.78},{"date":"2024-05-24","current":24.660746,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121128331641.95},{"date":"2024-05-31","current":24.726861,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121676961247.02},{"date":"2024-06-07","current":25.104265,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":123964258787.81},{"date":"2024-06-14","current":23.809521,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":116305279179.76},{"date":"2024-06-21","current":24.137339,"twenty":10.088339,"median":17.71521,"eighty":25.90586,"marketCap":117375957434.63},{"date":"2024-06-28","current":24.776447,"twenty":10.079688,"median":17.696545,"eighty":25.961437,"marketCap":120367749389.79},{"date":"2024-07-05","current":25.051924,"twenty":10.079688,"median":17.696545,"eighty":25.961437,"marketCap":122903385527.57},{"date":"2024-07-12","current":26.005076,"twenty":10.079688,"median":17.696545,"eighty":25.984495,"marketCap":128286809560.82},{"date":"2024-07-15","current":25.462386,"twenty":10.079688,"median":17.696545,"eighty":25.984495,"marketCap":126116902211.31},{"date":"2024-08-02","current":28.58221,"twenty":10.045539,"median":17.667431,"eighty":25.970775,"marketCap":129963975586.71},{"date":"2024-08-09","current":28.611937,"twenty":10.045539,"median":17.667431,"eighty":26.395222,"marketCap":131603672136.16},{"date":"2024-08-16","current":29.365903,"twenty":10.045539,"median":17.667431,"eighty":26.965608,"marketCap":135991482271.53},{"date":"2024-08-23","current":29.827758,"twenty":10.045539,"median":17.667431,"eighty":27.30154,"marketCap":139679917173.16},{"date":"2024-08-30","current":30.083408,"twenty":10.045539,"median":17.667431,"eighty":27.737312,"marketCap":140486982478.95},{"date":"2024-09-06","current":31.076279,"twenty":10.045539,"median":17.667431,"eighty":27.755808,"marketCap":145252320920.18},{"date":"2024-09-13","current":30.737395,"twenty":10.045539,"median":17.667431,"eighty":28.017403,"marketCap":143002491189.58},{"date":"2024-09-20","current":30.78296,"twenty":10.045539,"median":17.667431,"eighty":28.416222,"marketCap":144554419337.27},{"date":"2024-09-27","current":30.616469,"twenty":10.045539,"median":17.667431,"eighty":28.416222,"marketCap":144270741555.83},{"date":"2024-10-04","current":30.241865,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":140433638887.54},{"date":"2024-10-11","current":29.775602,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":137150593697.15},{"date":"2024-10-18","current":29.977793,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":136855848164.59},{"date":"2024-10-25","current":29.757762,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":135513851100.67},{"date":"2024-10-31","current":27.016329,"twenty":10.045539,"median":17.667431,"eighty":28.017403,"marketCap":132177608883.82},{"date":"2024-11-08","current":26.635368,"twenty":10.044628,"median":17.666414,"eighty":26.885017,"marketCap":129456333845.32},{"date":"2024-11-15","current":25.402919,"twenty":10.044628,"median":17.666414,"eighty":26.404422,"marketCap":121101937530.68},{"date":"2024-11-22","current":25.92038,"twenty":10.044628,"median":17.666414,"eighty":25.927346,"marketCap":122518864801.22},{"date":"2024-11-29","current":25.619919,"twenty":10.044628,"median":17.666414,"eighty":25.699083,"marketCap":121788536423.67},{"date":"2024-12-06","current":25.644957,"twenty":10.044628,"median":17.666414,"eighty":25.611269,"marketCap":122139495847.16},{"date":"2024-12-13","current":24.807559,"twenty":10.044628,"median":17.666414,"eighty":25.528111,"marketCap":117246552266.62},{"date":"2024-12-20","current":25.394572,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":118799775303.16},{"date":"2024-12-27","current":25.950983,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":121782054794.83},{"date":"2025-01-03","current":25.836919,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":119394068299.66},{"date":"2025-01-10","current":26.476134,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":122813940759.73},{"date":"2025-01-17","current":27.190583,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":126128028900.56},{"date":"2025-01-24","current":27.736112,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":130118603784.49},{"date":"2025-01-31","current":22.679241,"twenty":10.043718,"median":17.662753,"eighty":25.458421,"marketCap":135796476672.57},{"date":"2025-02-07","current":22.453317,"twenty":10.043718,"median":17.662753,"eighty":25.395685,"marketCap":133815994648.27},{"date":"2025-02-14","current":22.527177,"twenty":10.043718,"median":17.662753,"eighty":25.302609,"marketCap":135139535422.45},{"date":"2025-02-21","current":23.475533,"twenty":10.043718,"median":17.662753,"eighty":25.274251,"marketCap":136588490535.79},{"date":"2025-02-28","current":23.529645,"twenty":10.043718,"median":17.662753,"eighty":25.156716,"marketCap":136134051560.87},{"date":"2025-03-07","current":24.715596,"twenty":10.042807,"median":17.659092,"eighty":25.048936,"marketCap":148818188841.24},{"date":"2025-03-14","current":23.949012,"twenty":10.042807,"median":17.659092,"eighty":24.864048,"marketCap":144656712656.17},{"date":"2025-03-21","current":23.863334,"twenty":10.042807,"median":17.659092,"eighty":24.801725,"marketCap":143967164905.6},{"date":"2025-03-28","current":22.763528,"twenty":10.042807,"median":17.659092,"eighty":24.715596,"marketCap":136620485714.59},{"date":"2025-04-04","current":21.134417,"twenty":10.042807,"median":17.659092,"eighty":24.626125,"marketCap":130072347841.49},{"date":"2025-04-11","current":19.729859,"twenty":10.043718,"median":17.662753,"eighty":24.453364,"marketCap":122690991838.72},{"date":"2025-04-17","current":19.969823,"twenty":10.043718,"median":17.662753,"eighty":24.305248,"marketCap":126259056108.71},{"date":"2025-04-25","current":17.94759,"twenty":10.042807,"median":17.659092,"eighty":24.198495,"marketCap":128365926735.55},{"date":"2025-04-29","current":18.310973,"twenty":10.042807,"median":17.659092,"eighty":24.145603,"marketCap":131487479602.14}],"updateTime":1746050938338}}}